{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:28:18Z","timestamp":1761488898022},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s12094-012-0796-0","type":"journal-article","created":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T04:07:50Z","timestamp":1334549270000},"page":"280-286","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of liposomal cytarabine in children with primary CNS tumours with leptomeningeal involvement"],"prefix":"10.1007","volume":"14","author":[{"given":"Aurora","family":"Navajas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Lassaletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"L\u00f3pez-Ibor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantino","family":"S\u00e1bado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Moscard\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Sagaseta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,17]]},"reference":[{"key":"796_CR1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.taap.2003.12.029","volume":"199","author":"R.T. Baldwin","year":"2004","unstructured":"Baldwin RT, Preston-Martin S (2004) Epidemiology of brain tumors in childhood: a review. Toxicol Appl Pharmacol 199:118\u2013131","journal-title":"Toxicol Appl Pharmacol"},{"key":"796_CR2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/MOP.0b013e3282f0eafa","volume":"19","author":"S. Partap","year":"2007","unstructured":"Partap S, Fisher PG (2007) Update on new treatments and developments in childhood brain tumors. Curr Opin Pediatr 19:670\u2013674","journal-title":"Curr Opin Pediatr"},{"key":"796_CR3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/088307389501000304","volume":"10","author":"M.C. Chamberlain","year":"1995","unstructured":"Chamberlain MC (1995) A review of leptomeningeal metastases in pediatrics. J Child Neurol 10:191\u2013199","journal-title":"J Child Neurol"},{"key":"796_CR4","first-page":"1596","volume":"53","author":"S. Kim","year":"1993","unstructured":"Kim S, Khatibi S, Howell SB et al (1993) Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoam. Cancer Res 53:1596\u20131598","journal-title":"Cancer Res"},{"key":"796_CR5","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archneur.1995.00540330094020","volume":"52","author":"M.C. Chamberlain","year":"1995","unstructured":"Chamberlain MC, Kormanik P, Howell SB et al (1995) Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases. Arch Neurol 52:912\u2013917","journal-title":"Arch Neurol"},{"key":"796_CR6","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","volume":"17","author":"M.J. Glantz","year":"1999","unstructured":"Glantz MJ, LaFollette S, Jaeckle KA et al (1999) Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 17:3110\u20133116","journal-title":"J Clin Oncol"},{"key":"796_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-006-9218-x","volume":"81","author":"S. Phuphanich","year":"2007","unstructured":"Phuphanich S, Maria B, Braeckman R et al (2007) A pharmacokinetic study of intra-CSF adminis tered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study. J Neurooncol 81:201\u2013208","journal-title":"J Neurooncol"},{"key":"796_CR8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200645120-00002","volume":"45","author":"M.S. Angst","year":"2006","unstructured":"Angst MS, Drover DR (2006) Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology. Clin Pharmacokinet 45:1153\u20131176","journal-title":"Clin Pharmacokinet"},{"key":"796_CR9","unstructured":"FDA. Depocyt Approval Letter. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/99\/21-041_DepoCyt_Approv.pdf . Accessed19 May 2011"},{"key":"796_CR10","unstructured":"EMEA. Depocyte European Public Assessment Report. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/000317\/WC500035644. pdf . Accessed 19 May 2011"},{"key":"796_CR11","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2004.01.046","volume":"22","author":"L. Bomgaars","year":"2004","unstructured":"Bomgaars L, Geyer JR, Franklin J et al (2004) Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. J Clin Oncol 22:3916\u20133921","journal-title":"J Clin Oncol"},{"key":"796_CR12","unstructured":"Slavc I, Peyrl A, Gupper A et al (2006) Tolerability of intrathecal liposomal cytarabine at a dose 25\u201350 mg in children 11 months to 15 years old. 7th Congress EANO in Vienna, Austria, September 14\u201317, 2006. Abstract 130. Available at: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=1871663 . Accessed 8 February 2008"},{"key":"796_CR13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MPH.0b013e318041f112","volume":"29","author":"M. Benesch","year":"2007","unstructured":"Benesch M, Sovinz P, Krammer B et al (2007) Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis. J Pediatr Hematol Oncol 29:222\u2013226","journal-title":"J Pediatr Hematol Oncol"},{"issue":"[Suppl4]","key":"796_CR14","first-page":"444","volume":"47","author":"H. Bj\u00f6rgvinsd\u00f3ttir","year":"2006","unstructured":"Bj\u00f6rgvinsd\u00f3ttir H, Heldrup J, B\u00e9k\u00e1ssy A et al (2006) Intrathecal liposomal cytarabine: clinical experience in pediatric leukemia and neuroblastoma patients. Pediatr Blood Cancer 47[Suppl 4]:444","journal-title":"Pediatr Blood Cancer"},{"key":"796_CR15","doi-asserted-by":"crossref","unstructured":"Peyrl A, Sauermann R, Slavc I et al (2008) Safety and pharmacokinetics of intrathecal liposomal cytarabine (DepoCyte\u00ae) in children <= 3 years of age with malignant brain tumors. Presented at: 13th ISPNO International Symposium on Pediatric Neuro-Oncology, Chicago, USA","DOI":"10.2165\/00003088-200948040-00004"},{"key":"796_CR16","unstructured":"Lassaletta A, Navajas A, Sabado C et al (2007) Intrathecal liposomal cytarabine in children with brain tumors. Presented at: 39th Annual Conference SIOP, Mumbai, India"},{"key":"796_CR17","unstructured":"Lassaletta A, Navajas A et al (2008) Intrathecal liposomal cytarabine in children with brain tumors. Presented at: SIOP 2008, 40th Annual Conference of International Society of Paediactric Oncology, Berlin, Germany"},{"key":"796_CR18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11060-006-9327-6","volume":"83","author":"A. Lassaletta","year":"2007","unstructured":"Lassaletta A, Perez-Olleros P, Scaglione C et al (2007) Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child. J Neurooncol 83:303\u2013306","journal-title":"J Neurooncol"},{"key":"796_CR19","unstructured":"Napp Pharmaceuticals Limited (2009) Depo-Cyte 50 mg suspension for injection SPC. Available at: http:\/\/emc.medicines.org.uk\/document.aspx?documentId=15047 . Accessed 27 February 2009"},{"key":"796_CR20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00277-008-0521-9","volume":"87","author":"C. Sommer","year":"2008","unstructured":"Sommer C, Lackner H, Benesch M et al (2008) Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia. Ann Hematol 87:887\u2013890","journal-title":"Ann Hematol"},{"key":"796_CR21","unstructured":"Hospira. Cytarabine Injection Prescribing Information. Available at: http:\/\/www.hospira.com\/_docs\/Cytarabine%20483176-PROMOWEB.pdf ."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0796-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0796-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T10:04:57Z","timestamp":1561629897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0796-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0796-0","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}